Related references
Note: Only part of the references are listed.COVID-19 and ARDS: Update on Preventive and Therapeutic Venues
Arun Narota et al.
CURRENT MOLECULAR MEDICINE (2022)
A systematic review of asymptomatic infections with COVID-19
Zhiru Gao et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)
Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
Ernesto Carafoli
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
Zakariya Kashour et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects
Shiqin Li et al.
REVIEWS IN MEDICAL VIROLOGY (2021)
Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development
Sakthivel Suganya et al.
REVIEWS IN MEDICAL VIROLOGY (2021)
Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective
Mahshid Shahverdi et al.
CURRENT MOLECULAR MEDICINE (2021)
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
Amin Gasmi et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
Sabeena Ahmed et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Carlos Chaccour et al.
ECLINICALMEDICINE (2021)
The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta 1 heterodimer
Sundy N. Y. Yang et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
Daniel K. W. Chu et al.
CLINICAL CHEMISTRY (2020)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Connecting With Patients-The Missing Links
Lisa Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens
Jasper Fuk-Woo Chan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
Xin Liu et al.
JOURNAL OF GENETICS AND GENOMICS (2020)
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option
Tian-Tian Yao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Potential of large first generation human-to-human transmission of 2019-nCoV
Xingguang Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle
Hongzhou Lu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Jasper Fuk-Woo Chan et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Novel coronavirus takes flight from bats?
Ashley York
NATURE REVIEWS MICROBIOLOGY (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Camilla Rothe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
Junxiong Pang et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
Markus Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Paola Toniati et al.
AUTOIMMUNITY REVIEWS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
Wei Zhang et al.
EMERGING MICROBES & INFECTIONS (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
Jesus Villar et al.
LANCET RESPIRATORY MEDICINE (2020)
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
Naveen Vankadari
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wenling Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
Dan Zhou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
Zhen Zhu et al.
JOURNAL OF INFECTION (2020)
Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures
Ying Yan et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
Jianbo Tian et al.
LANCET ONCOLOGY (2020)
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
T. Klopfenstein et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Arbidol/IFN-a2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study
Ping Xu et al.
MICROBES AND INFECTION (2020)
Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020
Anne Kimball et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
CRISPR-Cas12-based detection of SARS-CoV-2
James P. Broughton et al.
NATURE BIOTECHNOLOGY (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
Muhammad Tahir ul Qamar et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
Chunguang Yang et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Coronavirus Disease 2019-COVID-19
Kuldeep Dhama et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Epidemiology and clinical features of COVID-19: A review of current literature
Juan A. Siordia
JOURNAL OF CLINICAL VIROLOGY (2020)
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta -analysis
Yong Hu et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR
Garrett A. Perchetti et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome
Loris Roncon et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
Yohei Doi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases
Somayeh Jolany Vangah et al.
BIOLOGICAL PROCEDURES ONLINE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Dexamethasone nanomedicines for COVID-19
Twan Lammers et al.
NATURE NANOTECHNOLOGY (2020)
The Covid-19 Vaccine-Development Multiverse
Penny M. Heaton
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Drugs against SARS-CoV-2: What do we know about their mode of action?
Coralie Valle et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review
Richard A. Giovane et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Emergence of novel coronavirus and progress toward treatment and vaccine
Muhammad Muzamil Khan et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Remdesivir: A beacon of hope from Ebola virus disease toCOVID-19
Ali Nili et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
Augusto Di Castelnuovo et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
Lucy Catteau et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
A. J. J. Lammers et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Interleukin-6 in Covid-19: A systematic review andmeta-analysis
Eric A. Coomes et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
CRISPR, the revolutionary genetic ‘scissors,’ honored by Chemistry Nobel
Jon Cohen
SCIENCE (2020)
Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID-19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series
Wei Gao et al.
VIROLOGY JOURNAL (2020)
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
Marzieh Nojomi et al.
BMC INFECTIOUS DISEASES (2020)
Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
Michael Takla et al.
SAUDI PHARMACEUTICAL JOURNAL (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series
Kent Doi et al.
CRITICAL CARE (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea
Moran Ki
EPIDEMIOLOGY AND HEALTH (2020)
Coronavirus envelope protein: current knowledge
Dewald Schoeman et al.
VIROLOGY JOURNAL (2019)
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection
Naoko Iwata-Yoshikawa et al.
JOURNAL OF VIROLOGY (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis
Jing-Wen Ai et al.
EMERGING MICROBES & INFECTIONS (2019)
Field-deployable viral diagnostics using CRISPR-Cas13
Cameron Myhrvold et al.
SCIENCE (2018)
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Janice S. Chen et al.
SCIENCE (2018)
Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry
Kazuya Shirato et al.
VIROLOGY (2018)
RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution
Sangita Venkataraman et al.
VIRUSES-BASEL (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
CRISPR-Cas12a-assisted nucleic acid detection
Shi-Yuan Li et al.
CELL DISCOVERY (2018)
Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China
Ning Wang et al.
VIROLOGICA SINICA (2018)
Prospects for a MERS-CoV spike vaccine
Yusen Zhou et al.
EXPERT REVIEW OF VACCINES (2018)
Nucleic acid detection with CRISPR-Cas13a/C2c2
Jonathan S. Gootenberg et al.
SCIENCE (2017)
Galidesivir, a Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus
So-Yon Lim et al.
Open Forum Infectious Diseases (2017)
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases
Md Abdul Alim Al-Bari
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
Vaccines for the prevention against the threat of MERS-CoV
Lanying Du et al.
EXPERT REVIEW OF VACCINES (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
Veronika Goetz et al.
SCIENTIFIC REPORTS (2016)
Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
Jonathan Shuter
Therapeutics and Clinical Risk Management (2016)
Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase-DNA Interaction
Jie An et al.
JOURNAL OF IMMUNOLOGY (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
Arbidol as a broad-spectrum antiviral: An update
Julie Blaising et al.
ANTIVIRAL RESEARCH (2014)
The SARS coronavirus nucleocapsid protein - Forms and functions
Chung-ke Chang et al.
ANTIVIRAL RESEARCH (2014)
CORONAVIRUS GENOMICS AND BIOINFORMATICS ANALYSIS
Patrick C. Y. Woo et al.
OMICS IN CLINICAL PRACTICE: GENOMICS, PHARMACOGENOMICS, PROTEOMICS, AND TRANSCRIPTOMICS IN CLINICAL RESEARCH (2014)
The Coronavirus Nucleocapsid Is a Multifunctional Protein
Ruth McBride et al.
VIRUSES-BASEL (2014)
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2013)
Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
M. Y. F. Tay et al.
ANTIVIRAL RESEARCH (2013)
Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication
Lindsay Lundberg et al.
ANTIVIRAL RESEARCH (2013)
Changes in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth
Lanhao Yang et al.
GLYCOBIOLOGY (2013)
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Jasper F. W. Chan et al.
JOURNAL OF INFECTION (2013)
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
Peter B. Madrid et al.
PLOS ONE (2013)
Interspecies transmission and emergence of novel viruses: lessons from bats and birds
Jasper Fuk-Woo Chan et al.
TRENDS IN MICROBIOLOGY (2013)
Favipiravir (T-705) inhibits in vitro norovirus replication
J. Rocha-Pereira et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
Miyuki Kawase et al.
JOURNAL OF VIROLOGY (2012)
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Alenka Kuznik et al.
JOURNAL OF IMMUNOLOGY (2011)
A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
Ana Shulla et al.
JOURNAL OF VIROLOGY (2011)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein
Jose L. Nieto-Torres et al.
VIROLOGY (2011)
Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
Shutoku Matsuyama et al.
JOURNAL OF VIROLOGY (2010)
Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology
Jody D. Berry et al.
MABS (2010)
Coronavirus Genomics and Bioinformatics Analysis
Patrick C. Y. Woo et al.
VIRUSES-BASEL (2010)
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Paul Saftig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Chloroquine Transport via the Malaria Parasite's Chloroquine Resistance Transporter
Rowena E. Martin et al.
SCIENCE (2009)
The pharmacokinetics and interactions of ivermectin in humans - A mini-review
Aranzazu Gonzalez Canga et al.
AAPS JOURNAL (2008)
Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
Masakazu Kono et al.
ANTIVIRAL RESEARCH (2008)
The SARS-CoV nucleocapsid protein: A protein with multifarious activities
Milan Surjit et al.
INFECTION GENETICS AND EVOLUTION (2008)
Lysosomal sequestration of amine-containing drugs: Analysis and therapeutic implications
Allyn M. Kaufmann et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus
AA Trujillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
B Morgenstern et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia
PCY Woo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)
LLM Poon et al.
CLINICAL CHEMISTRY (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases
JA Bruenn
NUCLEIC ACIDS RESEARCH (2003)
Early diagnosis of SARS Coronavirus infection by real time RT-PCR
LLM Poon et al.
JOURNAL OF CLINICAL VIROLOGY (2003)
Real-time PCR in virology
IM Mackay et al.
NUCLEIC ACIDS RESEARCH (2002)
Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses
RS Lanciotti et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus
IL Smith et al.
JOURNAL OF VIROLOGICAL METHODS (2001)
Localization of linear B-cell epitopes on infectious bronchitis virus nucleocapsid protein
JN Seah et al.
VETERINARY MICROBIOLOGY (2000)
Share Paper
